BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  Genentech’s Gazyva Helped People With Previously Untreated Follicular Lymphoma Live Significantly Longer Without Their Disease Worsening Compared To Rituxan

  December 5, 2016

   · 

  16 min read
• Drug Development

  Alexion Release: New Data From ALXN1210 Dose-Escalation Study Presented At American Society of Hematology Show Rapid And Sustained Reductions In LDH In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

  December 5, 2016

   · 

  14 min read
• Business

  Ferring Pharma Collaborates With Metabogen AB On Development Of Microbiome-Based Treatment For Intrahepatic Cholestasis Of Pregnancy (ICP)

  December 5, 2016

   · 

  3 min read
• Business

  Vizient, Inc. Joins Momentum To Measure And Improve Progress Toward Safer Chemicals In The Healthcare Industry

  December 5, 2016

   · 

  3 min read
• Drug Development

  Alnylam Reports Positive Interim Clinical Results For Fitusiran From Ongoing Phase 2 Open Label Extension Study In Patients With Hemophilia A Or B Without Inhibitors

  December 5, 2016

   · 

  12 min read
• Business

  Solasia Pharma K.K. And Meiji Seika Pharma Announce License And Distribution Agreement For Episil (Oral Liquid)

  December 5, 2016

   · 

  2 min read
• Bio NC

  Bioventus Release: Design Evolution Of EXOGEN Enhances Patient Compliance

  December 5, 2016

   · 

  2 min read
• Business

  Evogen And UCB Announce Collaboration For Further Development Of EvoScore START For Improved Diagnosis Of Epilepsy

  December 5, 2016

   · 

  5 min read
• Drug Development

  Alnylam Presents Updated Results From Phase I/II Study Of ALN-CC5 In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

  December 5, 2016

   · 

  13 min read
• Drug Development

  AstraZeneca PLC Release: Early Data Demonstrate Clinical Activity Of Acalabrutinib In Difficult-To-Treat Chronic Lymphocytic Leukemia

  December 5, 2016

   · 

  8 min read